According to an analyst from IMARC Group “The rising demand for biologics, vaccines and clinical trial materials means a potential business worth hundreds of billions of dollars, but it also means a huge need for reliable and efficient cold chain logistic services that can protect quality and efficacy of temperature sensitive healthcare products.” The report also suggests that regulatory agencies around the world have increased their scrutiny to ensure the integrity of healthcare products in the distribution chain.
The report, an updated and far more analytical version of our popular 2011 study, expects the total market for healthcare cold chain logistic services to grow robustly in the coming years. The study, that has been undertaken using both desk based and qualitative primary market research, has analyzed three aspects of the global healthcare cold chain logistics market.
The first aspect involves the quantification of the global market for temperature sensitive healthcare products into three major classes and evaluation of the current and future opportunities in each of these classes. The second aspect involves an in-depth understanding on the global healthcare cold chain distribution process and logistic requirements for various temperature sensitive healthcare products. The third aspect involves the quantification of the global healthcare cold chain logistic services market and a comprehensive evaluation of its various segments.
To buy the complete report or to get a free sample, please contact:
IMARC Group Asia
IMARC Group North America
IMARC Group Europe, Middle East & Africa
To know more please visit: http://www.imarcgroup.com/